Navigation Links
Existing drugs may help more breast cancer patients
Date:12/7/2012

More patients can benefit from highly effective breast cancer drugs that are already available, according to DNA sequencing studies by researchers at Washington University School of Medicine in St. Louis and other institutions.

The investigators found that some women with the HER2 negative subtype may benefit from anti-HER2 drugs even though standard tests don't indicate they are candidates for the drugs.

"These patients are going to be missed by our routine testing for HER2 positive breast cancer," says Ron Bose, MD, PhD, assistant professor of medicine. "Currently they're not going to receive a HER2 targeted drug because we don't have a way to identify them. And we predict they are going to have a more aggressive form of breast cancer."

Bose, who treats patients at Washington University's Siteman Cancer Center at Barnes-Jewish Hospital, will present the data Dec. 7 at the San Antonio Breast Cancer Symposium.

Today, a type of breast cancer known as HER2 positive is treated with drugs that inhibit the function of the HER2 protein. To be classified as HER2 positive, a patient must have more than the normal two copies of the HER2 gene. Too much HER2 drives tumor growth and some HER2 positive patients may have as many as 20 copies of the gene. Doctors test for this gene "amplification" in every patient diagnosed with breast cancer. It must be present for a woman to receive anti-HER2 drugs.

But instead of multiple copies of the gene churning out too much HER2, some patients deemed HER2 negative based on standard testing may have mistakes in just a few "letters" of the DNA in their two gene copies that result in excess activity of the protein. Bose and his colleagues estimate that these undetected HER2 mutations rather than the HER2 amplification -- may be driving tumor growth in 1.5 to 2 percent of all breast cancer patients. With about 230,000 new cases of breast cancer diagnosed in the United States each year, eve
'/>"/>

Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine
Source:Eurekalert  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments
2. Existing drugs offer new treatment options for high-risk childhood leukemia subtype
3. Mahvrick Expands to Brazil, Russia, India, China to Support Existing Client Customer Growth
4. Zane Benefits Publishes Information About Over-the-Counter (OTC) Medicines, Drugs and HRAs
5. Heart Failure Drugs Put to the Test
6. More New Drugs a Bad Fit With Grapefruit, Study Finds
7. Continued Use of ADHD Drugs May Reduce Criminal Behavior, Study Says
8. UAlberta prostate cancer researcher and team developing homing beacon drugs to target cancer cells
9. Can breast cancer cells reaction to cancer drugs be predicted?
10. Quick, high-volume test offers fast track in search for Alzheimers drugs
11. Structure of enzyme unravelled providing basis for more accurate design of chemotherapeutic drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Existing drugs may help more breast cancer patients
(Date:5/18/2013)... 2013 As metal-on-metal hip implant ... country, Bernstein Liebhard LLP notes that a new study ... tissue damage before they experience any pain from a ... Daily will appear in the Journal of Bone & ... screens of their hips. The researchers found tissue ...
(Date:5/18/2013)... Although obesity is associated with an ... obesity and esophageal adenocarcinoma, a type of esophageal cancer, ... As reported on Cancer.gov, last reviewed in January ... likely as those of normal and healthy weight to ... and esophageal cancer is not well understood, it is ...
(Date:5/18/2013)... 2013 The “Sleep Apnea Diagnostic & ... Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] ... analyzes and studies the major market drivers, restraints, and ... the World. , Browse , ... Figures , 318 pagesand in-depth TOC ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Adolescents, especially ... known as “Spice” or “K2” are landing in emergency ... to curb this drug epidemic with a new ... marijuana. , According to research from the National Institute ... popular illegal drug among American teenagers. In 2012, 11 ...
(Date:5/18/2013)... DF (PRWEB) May 18, 2013 The ... leading ayurvedic education institution in the West. Program is ... education. , Ayurveda is a healing modality practiced for ... ), it is considered that health begins when an ... profound understanding of their individual needs. Ayurveda aims to ...
Breaking Medicine News(10 mins):Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2
... 18 (HealthDay News) -- A new analysis of existing ... job of treating depression than standard care. Depression ... psychotherapy and antidepressant drugs. According to the analysis, one-third ... treated with four different medications. In addition, among depressed ...
... The BP oil spill in the Gulf of Mexico last ... coastal communities, even in areas where there was no direct ... of Maryland Medical Center and the University of Florida, Gainesville, ... in two fishing communities: Baldwin County, Ala., which had direct ...
... By Maryann Mott HealthDay Reporter , FRIDAY, Feb. ... best friends, but hospital records suggest some pooches feel otherwise. ... States are bitten by dogs, with some bites needing emergency ... hospital admissions caused by dog bites nearly doubled, increasing from ...
... the Children,s Center for Cancer and Blood Diseases and ... today announced a breakthrough discovery in understanding how the ... called CD19-ligand (CD19-L) located on the surface of certain ... of leukemia cells by the immune system. This ...
... , FRIDAY, Feb. 18 (HealthDay News) -- Tapping certain sequences ... German researchers suggest. For example, typing the numbers that ... trigger the feeling of that word in your mind, according ... University of Wurzburg. The researchers created a list of ...
... -- A disease the affects your legs could warn you ... million Americans over the age of 50 have peripheral arterial ... attack, according to the Vascular Disease Foundation and its PAD ... the foundation says. PAD occurs when arteries in the ...
Cached Medicine News:Health News:Peer Support Beats Usual Care for Depression, Analysis Finds 2Health News:Study Finds Widespread Trauma in Wake of BP Oil Spill 2Health News:Rise in Dog Bites Has Experts Concerned 2Health News:Rise in Dog Bites Has Experts Concerned 3Health News:Scientists bioengineer a protein to fight leukemia 2Health News:Using Cell Phones Might Evoke Emotions, Study Suggests 2Health News:Leg Discomfort Might Signal Heart Trouble 2
(Date:5/17/2013)... -- Atossa Genetics, Inc. (NASDAQ: ATOS ), The Breast ... , Chief Financial Officer & General Counsel, will present at ... 30, 2013, in New York City ... presentation is scheduled to begin at 3:30 p.m. EDT and ... webcast, go to www.atossagenetics.com . For more ...
(Date:5/17/2013)... 17, 2013  Boston Scientific Corporation (NYSE: ... EuroPCR Scientific Program May 21-24 in Paris ... a particularly rich and diversified set of data this ... , M.D., global chief medical officer, Boston Scientific.  "The ... including the NG PROMUS trial, which evaluated our Promus ...
(Date:5/16/2013)... 2013  Nektar Therapeutics, (Nasdaq: NKTR ) President ... , is scheduled to present at the upcoming 2013 UBS ... at the Sheraton New York Hotel on Tuesday, May 21, ... will be accessible via a Webcast through a link posted ... website: http://www.nektar.com . This Webcast will be available for ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... -- Global Pharm Holdings Group, Inc. (OTCBB: GPHG.OB) ... vertically integrated pharmaceutical company engaged in pharmaceutical related ... subsidiaries in the Anhui, Jilin, and Shandong provinces, ... first quarter ended March 31, 2011. ...
... Diagnostics, a leading developer of quantitative pulmonary imaging software, ... for the evaluation of pulmonary disease including chronic obstructive ... the 2011 International Conference of the American Thoracic Society ... been installed at leading pulmonary centers for validation and ...
Cached Medicine Technology:Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 2Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 3Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 4Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 5Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 6Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 7Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 8Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 9Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 10Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 11VIDA Diagnostics Launches Apollo Pulmonary Analysis Software for Major Lung Disease at American Thoracic Society Meeting 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: